Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2003-04-01
2008-10-07
Yu, Misook (Department: 1642)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
Reexamination Certificate
active
07432236
ABSTRACT:
Specific fragments of vasostatin are disclosed. Also disclosed is a method of stimulating the proliferation or survival of a hematopoietic cell exposed to a chemotherapeutic agent or irradiation using these fragments. A method of stimulating the proliferation or survival of a hematopoietic cell is also disclosed. In one embodiment, the method is disclosed for stimulating the growth or survival of a hematopoietic stem cell with a fragment of vasostatin, in the presence of a growth factor.
REFERENCES:
patent: 5192744 (1993-03-01), Bouck et al.
patent: 5426097 (1995-06-01), Stern et al.
patent: 5591716 (1997-01-01), Siebert et al.
patent: 5712291 (1998-01-01), D'Amato
patent: 5733876 (1998-03-01), O'Reilly et al.
patent: 5776704 (1998-07-01), O'Reilly et al.
patent: 5854202 (1998-12-01), Dedhar
patent: 5872234 (1999-02-01), Bandman et al.
patent: 2140814 (1996-07-01), None
patent: WO96/23001 (1996-08-01), None
patent: WO96/36643 (1996-11-01), None
patent: WO98/48003 (1998-10-01), None
Bowie et al.,Science247:1306-1310 (1990).
Burgess et al.,J. of Cell. Bio.111:2129-2138 (1990).
Cho et al.,Eur. J. Biochem.266:878-885 (1999).
Coppolino et al.,The International Journal of Biochemistry&Cell Biology32:171-188 (2000).
Lazar et al.,Molecular and Cellular Biology8:1247-1252 (1988).
McDonnell et al.,The Journal of Biological Chemistry271(14):7891-7894 (1996).
Michalak et al.,Biochem. J.285:681-692 (1992).
Patton et al.,The Journal of Biological Chemistry270(36):21404-21410 (1995).
Pike et al.,Blood94(9): 2461-2468 (1999).
Pozzan et al.,Physiological Reviews74(3):595-602 (1994).
Prasad et al.,Electrophoresis20:1065-1074 (1999).
Ramsamooj et al.,Cancer Research55:3016-3021 (1995).
Pike Sandra E.
Tosato Giovanna
Yao Lei
KLarquist Sparkman LLP
The United States of America as represented by the Secretary of
Yu Misook
LandOfFree
Vasostatin as marrow protectant does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vasostatin as marrow protectant, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vasostatin as marrow protectant will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4003698